IPOs

Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
Talaris pulls off $150M IPO to tackle organ rejection, autoimmune disorders
Fierce Biotech
Fri, 05/7/21 - 10:50 am
IPOs
Talaris Therapeutics
organ rejection
Hours before expected debut, Gyroscope postpones its IPO as 2 other biotechs hold the line on their march to Nasdaq
Endpoints
Fri, 05/7/21 - 10:33 am
IPOs
Gyroscope Therapeutics
Two Biotechs Gear Up for Nasdaq Debut
BioSpace
Tue, 05/4/21 - 10:47 pm
Gyroscope Therapeutics
Talaris Therapeutics
IPOs
NASDAQ
Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials
MedCity News
Sun, 05/2/21 - 10:16 pm
Werewolf Therapeutics
Vaccitech
IPOs
cancer immunotherapy
vaccines
This Is Why Zymergen's IPO Was a Huge Success
Motley Fool
Tue, 04/27/21 - 11:31 pm
Zymergen
IPOs
synthetic biology
Molecular Partners Files $100 Million IPO to Advance COVID-19 and Cancers Therapies
BioSpace
Sun, 04/25/21 - 01:47 pm
Molecular Partners
IPOs
3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq
Fierce Biotech
Mon, 04/19/21 - 11:08 am
IPOs
NASDAQ
Talaris Therapeutics
Gyroscope Therapeutics
Sagimet Biosciences
Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO
Fierce Biotech
Tue, 04/13/21 - 10:24 am
Recursion Pharmaceuticals
IPOs
artificial intelligence
COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO
Fierce Biotech
Mon, 04/12/21 - 11:25 pm
Valneva
IPOs
COVID-19
Pfizer
Reneo Pharmaceuticals and VectivBio Prepare to Begin Trading on the Nasdaq
BioSpace
Thu, 04/8/21 - 07:51 pm
Reneo Pharmaceuticals
VectivBio
IPOs
NASDAQ
The flotation window stays open, for now
EP Vantage
Thu, 04/8/21 - 10:26 am
IPOs
biotech
flotation
Vaccitech confidentially files for Nasdaq IPO
Endpoints
Wed, 04/7/21 - 07:20 pm
Vaccitech
IPOs
NASDAQ
COVID-19
vaccines
After name change and dropped IPO, IN8bio tries again to boost its cancer pipeline
Fierce Biotech
Mon, 04/5/21 - 10:30 pm
IN8Bio
Incysus Therapeutics
IPOs
Rain Therapeutics headlines newest slate of IPO-bound biotechs with $100M penciled in for lead oncology program
Endpoints
Mon, 04/5/21 - 10:21 pm
IPOs
Rain Therapeutics
Impel NeuroPharma
Anebulo Pharmaceuticals
Achilles Therapeutics’ IPO nabs $175M to bring cell therapies to solid tumors
MedCity News
Thu, 04/1/21 - 10:47 am
Achilles Therapeutics
IPOs
cancer immunotherapy
Three Biopharma Companies Making Their Nasdaq Debut
BioSpace
Mon, 03/29/21 - 10:49 am
IPOs
NASDAQ
Design Therapeutics
Edgewise Therapeutics
Ikena Oncology
Gyroscope bags $148M for AMD gene therapy trials, mulls IPO
Fierce Biotech
Fri, 03/26/21 - 10:53 am
Gyroscope
gene therapy
IPOs
age-related macular degeneration
British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO
Fierce Biotech
Fri, 03/26/21 - 10:44 am
IPOs
Achilles Therapeutics
immuno-oncology
NASDAQ
Recursion will take its AI platform public in latest IPO filing, while rare heart mutation biotech jumps on SPAC train
Endpoints
Tue, 03/23/21 - 10:31 am
Recursion Pharmaceuticals
IPOs
artificial intelligence

Pages